Oxytocin — reference
Posterior pituitary hormone; approved as an injection for labor induction and postpartum hemorrhage. Intranasal and compounded forms are used off-label for social and behavioural effects.
Regulatory status
FDA-Approved (labeled use). FDA-approved (Pitocin) for obstetric indications only. Intranasal oxytocin for mood, bonding or social effects is not an approved use.
Reported cautions
Pharmacokinetics
Published figures give an elimination half-life of ~1–6 minutes. Well-studied; cleared very fast regardless of route.
This figure is tagged PK study in our evidence system. This figure comes from a published pharmacokinetic study rather than a label or registration trial. Sample sizes in such studies are often small and figures vary between them, so treat the number as a range rather than a constant. You can see the shape this implies between doses in the Half-Life Visualizer, and compare it against every other compound in the Half-Life Data Table. Our sourcing page explains what each tier means.
Remember that an estimated curve is a model built from a population figure, not a measurement of your blood. Individual clearance varies, and for depot injections the figure describes release from the injection site rather than the compound clearing. Half-life explained →
What Peptide Plug does and does not publish
This page carries regulatory status, general context and published pharmacokinetics. It carries no dose, frequency or cycle information — that is a deliberate editorial line, because dosing is a clinical decision rather than reference data. We also do not sell, supply, source or link to vendors for any compound.
Frequently asked
Is Oxytocin FDA-approved?
What is the half-life of Oxytocin?
How reliable is that half-life figure?
What cautions are associated with Oxytocin?
Does Peptide Plug publish dosing for Oxytocin?
Does Peptide Plug sell Oxytocin?
Related tools
Free, no account required.